{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:03:30Z","timestamp":1783764210140,"version":"3.55.0"},"reference-count":50,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["68633259"],"award-info":[{"award-number":["68633259"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2024,7,5]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Chronic inflammation promotes cardiovascular risk in rheumatoid arthritis (RA). Biological disease-modifying antirheumatic drugs (bDMARDs) improve disease activity and cardiovascular disease outcomes. We explored whether bDMARDs influence the impact of disease activity and inflammatory markers on long-term cardiovascular risk in RA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We studied 4370 participants without cardiovascular disease in a 10-country observational cohort of patients with RA. Endpoints were (1) major adverse cardiovascular events (MACE) encompassing myocardial infarction, stroke and cardiovascular death; and (2) any ischaemic cardiovascular events (iCVE) including MACE plus revascularisation, angina, transient ischaemic attack and peripheral arterial disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Over 26\u2009534 patient-years, 239 MACE and 362 iCVE occurred. The interaction between 28-joint Disease Activity Score with C-reactive protein (DAS28-CRP) and bDMARD use was significant for MACE (p=0.017), suggesting the effect of DAS28-CRP on MACE risk differed among bDMARD users (n=515) and non-users (n=3855). DAS28-CRP (per unit increase) is associated with MACE risk in bDMARD non-users (HR 1.21 (95% CI 1.07 to 1.37)) but not users (HR 0.69 (95% CI 0.40 to 1.20)). The interaction between CRP (per log unit increase) and bDMARD use was also significant for MACE (p=0.011). CRP associated with MACE risk in bDMARD non-users (HR 1.16 (95% CI 1.04 to 1.30)), but not users (HR 0.65 (95% CI 0.36 to 1.17)). No interaction was observed between bDMARD use and DAS28-CRP (p=0.167) or CRP (p=0.237) for iCVE risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>RA activity and inflammatory markers associated with risk of MACE in bDMARD non-users but not users suggesting the possibility of biological-specific benefits locally on arterial wall independently of effects on systemic inflammation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2024-004546","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T22:36:13Z","timestamp":1721774173000},"page":"e004546","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-1563","authenticated-orcid":false,"given":"George Athanasios","family":"Karpouzas","sequence":"first","affiliation":[{"name":"Internal Medicine - Rheumatology, The Lundquist Institute, Torrance, California, USA"},{"name":"Rheumatology, Harbor-UCLA Medical Center, Torrance, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R","family":"Ormseth","sequence":"additional","affiliation":[{"name":"The Lundquist Institute, Torrance, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet Leonardus Cornelis Maria","family":"van Riel","sequence":"additional","affiliation":[{"name":"IQ Healthcare, Radboud University, Nijmegen, Gelderland, Netherlands"},{"name":"Rheumatology, Bernhoven Hospital Location Oss, Oss, Noord-Brabant, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7924-7406","authenticated-orcid":false,"given":"Miguel A","family":"Gonzalez-Gay","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain"},{"name":"IIS-Fundacion Jimenez Diaz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Corrales","sequence":"additional","affiliation":[{"name":"Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-3863","authenticated-orcid":false,"given":"Solbritt","family":"Rantap\u00e4\u00e4-Dahlqvist","sequence":"additional","affiliation":[{"name":"Department of Public Health and Clinical Medicine\/Rheumatology, Umea Universitet, Umea, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros P","family":"Sfikakis","sequence":"additional","affiliation":[{"name":"First Dept. of Propedeutic Medicine, University of Athens, Athens, Attica, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dessein","sequence":"additional","affiliation":[{"name":"School of Physiology, University of the Witwatersrand Johannesburg, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Tsang","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Brussel, Brussel, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Hitchon","sequence":"additional","affiliation":[{"name":"Rheumatology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"El-Gabalawy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7368-498X","authenticated-orcid":false,"given":"Virginia","family":"Pascual-Ramos","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraz\u00fa","family":"Contreras-Y\u00e1\u00f1ez","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2786-5843","authenticated-orcid":false,"given":"Iris J","family":"Colunga-Pedraza","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitario Dr Jos\u00e9 Eleuterio Gonz\u00e1lez, Monterrey, Nuevo Le\u00f3n, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9714-2109","authenticated-orcid":false,"given":"Dionicio Angel","family":"Galarza-Delgado","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Le\u00f3n, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ramon","family":"Azpiri-Lopez","sequence":"additional","affiliation":[{"name":"Hospital Universitario Dr Jos\u00e9 Eleuterio Gonz\u00e1lez, Monterrey, Nuevo Le\u00f3n, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-2853","authenticated-orcid":false,"given":"Anne Grete","family":"Semb","sequence":"additional","affiliation":[{"name":"Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-7396","authenticated-orcid":false,"given":"Durga Prasanna","family":"Misra","sequence":"additional","affiliation":[{"name":"Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen-Margrethe","family":"Hauge","sequence":"additional","affiliation":[{"name":"Department of Joint and Connective Tissue Diseases, Aarhus Universitetshospital, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus Universitet, Aarhus, Midtjylland, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kitas","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Dudley Group NHS Foundation Trust, Dudley, West Midlands, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"2025090312564000000_10.3.e004546.1","doi-asserted-by":"crossref","first-page":"102925","DOI":"10.1016\/j.autrev.2021.102925","article-title":"Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus","volume":"21","author":"Restivo","year":"2022","journal-title":"Autoimmun Rev"},{"key":"2025090312564000000_10.3.e004546.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203617"},{"key":"2025090312564000000_10.3.e004546.3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/art.41122","article-title":"Impact of cumulative inflammation, cardiac risk factors, and medication exposure on coronary atherosclerosis progression in rheumatoid arthritis","volume":"72","author":"Karpouzas","year":"2020","journal-title":"Arthritis & Rheumatology"},{"key":"2025090312564000000_10.3.e004546.4","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223302"},{"key":"2025090312564000000_10.3.e004546.5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.120410"},{"key":"2025090312564000000_10.3.e004546.6","doi-asserted-by":"crossref","unstructured":"Karpouzas GA , Szekanecz Z , Baecklund E , et al . Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL surveillance. Ther Adv Musculoskelet Dis 2023;15. doi:10.1177\/1759720X231201047","DOI":"10.1177\/1759720X231201047"},{"key":"2025090312564000000_10.3.e004546.7","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/art.39098","article-title":"Disease activity in rheumatoid arthritis and the risk of cardiovascular events","volume":"67","author":"Solomon","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025090312564000000_10.3.e004546.8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/1744666X.2021.1899809","article-title":"Biologics and atherosclerotic cardiovascular risk in rheumatoid arthritis: a review of evidence and mechanistic insights","volume":"17","author":"Karpouzas","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"2025090312564000000_10.3.e004546.9","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/art.41293","article-title":"Biologics may prevent cardiovascular events in rheumatoid arthritis by inhibiting coronary plaque formation and stabilizing high-risk lesions","volume":"72","author":"Karpouzas","year":"2020","journal-title":"Arthritis & Rheumatology"},{"key":"2025090312564000000_10.3.e004546.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914"},{"key":"2025090312564000000_10.3.e004546.11","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05230-0"},{"key":"2025090312564000000_10.3.e004546.12","article-title":"Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a cochrane systematic review and network meta-analysis (NMA)","volume":"11","author":"Singh","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090312564000000_10.3.e004546.13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14740338.2016.1218469","article-title":"Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease: a focus on rheumatoid arthritis","volume":"15","author":"Tocci","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"2025090312564000000_10.3.e004546.14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.067660"},{"key":"2025090312564000000_10.3.e004546.15","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.129916"},{"key":"2025090312564000000_10.3.e004546.16","first-page":"658","article-title":"Effects of biologic disease-modifying anti-rheumatic drugs on the radiographic progression of rheumatoid arthritis: a systematic literature review","volume":"36","author":"Combe","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2025090312564000000_10.3.e004546.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.22809"},{"key":"2025090312564000000_10.3.e004546.18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211735"},{"key":"2025090312564000000_10.3.e004546.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174656","article-title":"Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis","volume":"12","author":"Crowson","year":"2017","journal-title":"PLoS One"},{"key":"2025090312564000000_10.3.e004546.20","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-016-1077-z","article-title":"Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis","volume":"18","author":"Meissner","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2025090312564000000_10.3.e004546.21","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2018.00185","article-title":"The utility and limitations of CRP, ESR and Das28-CRP in appraising disease activity in rheumatoid arthritis","volume":"5","author":"Orr","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"2025090312564000000_10.3.e004546.22","doi-asserted-by":"crossref","DOI":"10.1186\/ar4469","article-title":"Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year","volume":"16","author":"Kay","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2025090312564000000_10.3.e004546.23","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-016-1008-z","article-title":"Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study","volume":"18","author":"Bernelot Moens","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2025090312564000000_10.3.e004546.24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160145","article-title":"Targeting tumor necrosis factor-\u0391 with adalimumab: effects on endothelial activation and monocyte adhesion","volume":"11","author":"Oberoi","year":"2016","journal-title":"PLoS One"},{"key":"2025090312564000000_10.3.e004546.25","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.40"},{"key":"2025090312564000000_10.3.e004546.26","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.307736"},{"key":"2025090312564000000_10.3.e004546.27","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s10554-016-0957-2","article-title":"Dynamic change of high-risk plaque detected by coronary computed tomographic angiography in patients with subclinical coronary artery disease","volume":"32","author":"Iwasaki","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"key":"2025090312564000000_10.3.e004546.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.07.078"},{"key":"2025090312564000000_10.3.e004546.29","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/art.39039","article-title":"Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism","volume":"67","author":"Ronda","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025090312564000000_10.3.e004546.30","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002411","article-title":"Serum cholesterol loading capacity on macrophages is linked to coronary atherosclerosis and cardiovascular event risk in rheumatoid arthritis","volume":"8","author":"Karpouzas","year":"2022","journal-title":"RMD Open"},{"key":"2025090312564000000_10.3.e004546.31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2023.100209","article-title":"Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis","volume":"7","author":"Karpouzas","year":"2023","journal-title":"J Transl Autoimmun"},{"key":"2025090312564000000_10.3.e004546.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.054"},{"key":"2025090312564000000_10.3.e004546.33","first-page":"2724","article-title":"The feasibility of using Hcy, CRP, and Cys-C to analyze AMI patients\u2019 disease conditions and prognoses","volume":"13","author":"Zhang","year":"2021","journal-title":"Am J Transl Res"},{"key":"2025090312564000000_10.3.e004546.34","doi-asserted-by":"publisher","DOI":"10.4238\/2014.June.9.11"},{"key":"2025090312564000000_10.3.e004546.35","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3892\/etm.2014.1565","article-title":"Correlation between the severity of coronary artery lesions and levels of estrogen, Hs-CRP and MMP-9","volume":"7","author":"Guo","year":"2014","journal-title":"Exp Ther Med"},{"key":"2025090312564000000_10.3.e004546.36","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1999.1049"},{"key":"2025090312564000000_10.3.e004546.37","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001882","article-title":"Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trials","volume":"7","author":"Law-Wan","year":"2021","journal-title":"RMD Open"},{"key":"2025090312564000000_10.3.e004546.38","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1093\/rheumatology\/kez188","article-title":"Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor-treated rheumatoid arthritis patients","volume":"58","author":"Hamann","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312564000000_10.3.e004546.39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken002"},{"key":"2025090312564000000_10.3.e004546.40","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/1756-185X.13996","article-title":"Chinese registry of rheumatoid arthritis (CREDIT): III. The transition of disease activity during follow-ups and predictors of achieving treatment target","volume":"23","author":"Xiang","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"2025090312564000000_10.3.e004546.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2007.10.037"},{"key":"2025090312564000000_10.3.e004546.42","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1038\/s41598-024-55575-8","article-title":"Identification of key genes for atherosclerosis in different arterial beds","volume":"14","author":"Wu","year":"2024","journal-title":"Sci Rep"},{"key":"2025090312564000000_10.3.e004546.43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.789172"},{"key":"2025090312564000000_10.3.e004546.44","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.20.4.511"},{"key":"2025090312564000000_10.3.e004546.45","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1161\/01.ATV.20.8.1998","article-title":"Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth","volume":"20","author":"McGill","year":"2000","journal-title":"ATVB"},{"key":"2025090312564000000_10.3.e004546.46","first-page":"9","article-title":"Do hypertension and diabetes mellitus influence the site of atherosclerotic plaques","volume":"157","author":"Danese","year":"2006","journal-title":"Clin Ter"},{"key":"2025090312564000000_10.3.e004546.47","first-page":"1018","article-title":"Hemodynamics and atherosclerosis. insights and perspectives gained from studies of human arteries","volume":"112","author":"Glagov","year":"1988","journal-title":"Arch Pathol Lab Med"},{"key":"2025090312564000000_10.3.e004546.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.02.004"},{"key":"2025090312564000000_10.3.e004546.49","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.486480"},{"key":"2025090312564000000_10.3.e004546.50","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00170-3"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2024-004546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:56:53Z","timestamp":1756929413000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2024-004546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,7,23]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/rmdopen-2024-004546"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2024-004546","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}